Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Tate & Lyle reports solid year, completes Primient exit
(Sharecast News) - Tate & Lyle reported a robust full-year financial performance driven by strong profit and cash metrics on Wednesday, as it also announced the sale of its stake in American firm Primient. The FTSE 250 company said adjusted EBITDA rose 7% year-on-year in the 12 months ended 31 March to £328m, with a significant increase in the EBITDA margin of 170 basis points to 19.9%.
That growth was largely attributed to proactive mix management, productivity savings, and stringent cost discipline.
Despite a slight 2% decline in overall revenue to £1.65bn, Tate & Lyle said its strategic focus on margin prioritisation over volume had paid off.
The company's food and beverage solutions segment generated £1.36bn in revenue, while Sucralose contributed £174m.
EBITDA for the segments stood at £281m and £52m, respectively.
Profit before tax increased 18% to £287m, driven by the growth in food and beverage solutions, an increased share of profit from Primient, and lower finance charges.
Additionally, earnings per share rose 18% to 55.5p, and free cash flow improved by £49m to £170m.
Tate & Lyle also announced that it had completed the sale of its remaining interest in Primient for $350m, marking its transformation into a specialty food and beverage solutions business.
The net proceeds from the sale would be returned to shareholders through a share buyback program.
It said the transaction, expected to complete by the end of July, finalised its exit from Primient ahead of schedule, significantly enhancing its cash position and enabling further shareholder returns.
The company said its strong productivity performance resulted in $41m in savings, prompting an increase in its five-year savings target to $150m.
Additionally, the company saw an improvement in its organic return on capital employed by 40 basis points.
Tate & Lyle recommended a final dividend of 12.9p per share, leading to a full-year dividend of 19.1p per share, up 3.2% from the prior year.
Looking ahead, Tate & Lyle anticipated revenue to be slightly lower in the coming year due to input cost deflation, but expected EBITDA growth of between 4% and 7%.
The company said it was poised for good volume growth in 2025 as consumer confidence improved and customer destocking ended.
"In challenging market conditions, it's been another year of robust financial performance and strategic progress, with strong profit growth and productivity delivery, excellent cash generation, and further progress to transform the business," said chief executive officer Nick Hampton.
"The actions taken over the last six years have created a higher quality and more resilient business, with the agility to navigate the challenging economic environment and softer consumer demand we saw last year.
"While managing these short-term market dynamics, we also continued to set up the business for long-term growth by increasing investment in technology, innovation, solution selling and new capacity, and by intentionally moving away from low margin business."
Hampton said he was "particularly pleased" by the firm's progress building its solutions business with customers - a core element of its strategy - with solutions new business wins continuing to grow.
"The separate announcement we made today of the sale of our remaining stake in Primient represents an important milestone for our business.
"With this sale, the transformation of Tate & Lyle into a fully-focused speciality food and beverage solutions business is complete.
"We are now well-positioned to capture the significant growth opportunities ahead as we look to provide our customers with the solutions they need to meet growing consumer demand for healthier, tastier and more sustainable food and drink."
At 0947 BST, shares in Tate & Lyle were up 4.8% at 709.49p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.